Increasing evidence suggests that inflammation is associated with the development of acute ischemic stroke (AIS). The neutrophil-to-lymphocyte ratio (N/L) is an important marker of inflammation and is highly correlated with mortality in stroke patients in recent studies. The N/L of patients who experience hemorrhagic transformation (HT) after AIS is know, but any relationship between N/L and large artery atherosclerosis (LAA) remains unclear, this is our present topic. We enrolled 185 patients with LAA-type HT in the development cohort from a prospective, consecutive, hospital-based stroke registry to this end. We matched these patients to 213 LAA patients who did not develop HT as controls. The incidence of HT after LAA was significantly greater (P<0.01) in patients with higher N/L. We developed a predictive nomogram (incorporating age, systolic blood pressure, the National Institutes of Health Stroke Scale, and the N/L) for LAA patients. The predictive power was good (area under the curve, AUC: 0.832, 95%CI: 0.791-0.872). Our findings were further validated in a validation cohort of 202 patients with AIS attributable to LAA (AUC:0.836, 95%CI:0.781-0.891). In summary, a high N/L is associated with an increased risk for HT after LAA.
Focused microwave hyperthermia is a noninvasive, non-ionizing, and accurate treatment method that is promising for dealing with many kinds of cancers. Although focused microwave brain hyperthermia (FMBH) has been studied by some previous works, experimental evaluation of this technique in a practical experimental context has not been reported. This article aims to address this issue by developing a preclinical system prototype of FMBH and performing systematic experimental evaluation using several realistic head phantoms. We designed a 1.3-GHz hyperthermia applicator with 17 antennas and built nine different head phantoms based on a real human skull. We perform electromagnetic and thermal simulations and prove that the designed applicator can reliably achieve a good focused field and 45 $^{\circ}$ C temperature at the tumor. We then realize the FMBH system prototype and experimentally test the performance by applying fabricated 3-D head phantoms. The measured temperature results demonstrate that the FMBH system prototype is able to selectively treat the tumor. We also prove that the temperature at the tumor can be controlled at a constant level for a demanded time period for hyperthermia. This work provides a valuable experimental demonstration of the FMBH technique and is meaningful for its future development and clinical applications.